TDOC Teladoc Health, Inc.
Q3 2025 10-Q
Filed: Oct 30, 2025Period ending Sep 30, 2025
Health Care
Services-Offices & Clinics of Doctors of MedicineSEC EDGAR Teladoc Health, Inc. (TDOC) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New operational risk: CFO Mala Murthy resignation effective Nov 21, 2025, CEO Charles Divita to serve as interim principal financial officer
- • Financial risk update: Credit Agreement dated July 17, 2025, with JPMorgan Chase Bank as administrative agent executed July 23, 2025
Get deeper insights on Teladoc Health, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.